BIOFIRE MOLECULAR ANALYZER AT NHCP

Contract HT941026PE064 is a firm fixed price award granted by the Defense Health Agency to Biofire Defense LLC for the provision of Cost Per Test Molecular Assay Testing services at the Naval Hospital Camp Pendleton in California. The scope of work includes the delivery of a molecular assay analyzer along with all necessary reagents, consumables, and ongoing maintenance. The contract is structured with a base period running from April 15, 2026, to September 30, 2026, and five subsequent option periods extending through April 14, 2031. The total estimated contract value ranges from a base period cost of 425,647.66 USD to a maximum of 4,651,935.82 USD if all option periods are exercised. Performance and delivery are designated as FOB Destination, with inspection and acceptance conducted by the government at the Naval Hospital Camp Pendleton. The contractor must adhere to strict regulatory and security standards, including DHA Cybersecurity-RMF requirements, NIST SP 800-171 security controls, and various DFARS prohibitions regarding covered telecommunications equipment and foreign business operations. Administrative management is handled through the Web-Based Automated Workflow System for invoicing and payments, with oversight provided by the Defense Health Agency Healthcare Contracting Division West.